Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397911
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-30
Brief Title:
Evaluate Efficacy Pharmacokinetics and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Oneness Biotech Co Ltd
Organization:
Oneness Biotech Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-16
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
April 30 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL